000 | 01989 a2200505 4500 | ||
---|---|---|---|
005 | 20250517042536.0 | ||
264 | 0 | _c20161223 | |
008 | 201612s 0 0 eng d | ||
022 | _a1464-5491 | ||
024 | 7 |
_a10.1111/dme.12844 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeller, S R | |
245 | 0 | 0 |
_aSevere hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. _h[electronic resource] |
260 |
_bDiabetic medicine : a journal of the British Diabetic Association _cApr 2016 |
||
300 |
_a471-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCosts and Cost Analysis |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
650 | 0 | 4 | _aHealth Care Costs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 |
_aInsulin Aspart _xadministration & dosage |
650 | 0 | 4 |
_aInsulin Detemir _xadministration & dosage |
650 | 0 | 4 |
_aInsulin Glargine _xadministration & dosage |
650 | 0 | 4 |
_aInsulin, Long-Acting _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSitagliptin Phosphate _xadministration & dosage |
700 | 1 | _aFrier, B M | |
700 | 1 | _aHersløv, M L | |
700 | 1 | _aGundgaard, J | |
700 | 1 | _aGough, S C L | |
773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 33 _gno. 4 _gp. 471-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/dme.12844 _zAvailable from publisher's website |
999 |
_c25078787 _d25078787 |